Résumé
Familial hypercholesterolemia (FH) is a highly prevalent autosomal dominant dyslipidemia. Without appropriate treatment, patients are exposed to a cardiovascular risk 13 times higher than a non-affected subject. The condition remains under-diagnosed and under-treated. Contraception refers to all the methods and techniques used to prevent unwanted pregnancy. There are different methods (hormonal, intra-uterine devices, barriers, natural) which can be used according to the patient's individual needs (age, state of health, presence of risk factors, lifestyle, personal preferences, etc.). More than seven out of ten women (71.8%) use a medical method for contraception. The aim of this study is to investigate the links that may exist between contraception and hypercholesterolemia, and above all, to highlight the importance of an individualized medical approach to reducing cardiovascular risk in women with dyslipidemia. Research highlights the need for a cautious, individualized approach to contraceptive choice for women with familial hypercholesterolemia. Interactions between contraceptive methods and cholesterol require extra vigilance to prevent cardiovascular complications. By adapting contraceptive strategies to patients' lipid profiles, it is possible to significantly reduce risks while ensuring effective protection against unwanted pregnancies.